antimycotics	are	drugs
antimycotics	treat	fungal infections
antimycotics	include	azoles
antimycotics	include	polyenes
antimycotics	include	echinocandins
antimycotics	include	allylamines
antimycotics	include	pyrimidine analogs
azoles	inhibit	ergosterol synthesis
azoles	target	cytochrome P450
azoles	cause	hepatotoxicity
azoles	cause	QT prolongation
azoles	used for	candidiasis
azoles	used for	aspergillosis
azoles	used for	cryptococcosis
azoles	interact with	statins
azoles	interact with	warfarin
azoles	interact with	antiretrovirals
azoles	contraindicated in	pregnancy
azoles	contraindicated in	liver disease
azoles	contraindicated in	renal failure
azoles	dosage	weight-based
azoles	dosage	renal-adjusted
azoles	dosage	hepatic-adjusted
azoles	monitored by	liver enzymes
azoles	monitored by	ECG
azoles	monitored by	drug levels
azoles	monitored by	therapeutic drug monitoring
polyene	bind	ergosterol
polyene	disrupt	fungal cell membrane
polyene	cause	nephrotoxicity
polyene	cause	infusion reactions
polyene	used for	invasive aspergillosis
polyene	used for	cryptococcal meningitis
polyene	used for	mucormycosis
polyene	dosage	weight-based
polyene	dosage	renal-adjusted
polyene	monitored by	serum creatinine
polyene	monitored by	infusion rate
polyene	monitored by	blood levels
echinocandin	inhibit	β‑1,3‑glucan synthase
echinocandin	disrupt	fungal cell wall
echinocandin	cause	infusion reactions
echinocandin	cause	mild hepatotoxicity
echinocandin	used for	candidemia
echinocandin	used for	invasive candidiasis
echinocandin	used for	aspergillosis
echinocandin	dosage	weight-based
echinocandin	dosage	renal-adjusted
echinocandin	monitored by	liver enzymes
echinocandin	monitored by	trough levels
allylamine	inhibit	squalene epoxidase
allylamine	cause	hepatotoxicity
allylamine	cause	photosensitivity
allylamine	used for	tinea versicolor
allylamine	used for	pityriasis versicolor
allylamine	dosage	weight-based
allylamine	dosage	renal-adjusted
allylamine	monitored by	liver enzymes
pyrimidine analog	inhibit	DNA synthesis
pyrimidine analog	cause	myelosuppression
pyrimidine analog	cause	mucositis
pyrimidine analog	used for	cryptococcal meningitis
pyrimidine analog	used for	histoplasmosis
pyrimidine analog	dosage	weight-based
pyrimidine analog	dosage	renal-adjusted
pyrimidine analog	monitored by	blood counts
pyrimidine analog	monitored by	liver enzymes
antimycotics	increase	mortality risk
antimycotics	reduce	infection recurrence
antimycotics	improve	survival in invasive candidiasis
antimycotics	improve	survival in invasive aspergillosis
antimycotics	improve	survival in cryptococcosis
antimycotics	improve	survival in mucormycosis
antimycotics	associated with	drug interactions
antimycotics	associated with	adverse events
antimycotics	associated with	therapeutic drug monitoring
antimycotics	associated with	dosage adjustments
antimycotics	associated with	renal toxicity
antimycotics	associated with	hepatic toxicity
antimycotics	associated with	infusion reactions
antimycotics	associated with	QT prolongation
antimycotics	associated with	photosensitivity
antimycotics	associated with	myelosuppression
antimycotics	associated with	mucositis
antimycotics	used in	ICU patients
antimycotics	used in	immunocompromised patients
antimycotics	used in	transplant recipients
antimycotics	used in	neutropenic patients
antimycotics	used in	patients with central venous catheters
antimycotics	used in	patients with pulmonary aspergillosis
antimycotics	used in	patients with CNS fungal infections
antimycotics	used in	patients with mucormycosis
antimycotics	used in	patients with cryptococcal meningitis
antimycotics	used in	patients with histoplasmosis
antimycotics	used in	patients with blastomycosis
antimycotics	used in	patients with coccidioidomycosis
antimycotics	used in	patients with dermatophyte infections
antimycotics	used in	patients with systemic fungal infections
antimycotics	used in	patients with invasive fungal infections
antimycotics	used in	patients with high mortality risk
